Anticholinergic-type effects following a pediatric venlafaxine overdose.
Miller
Tanner
T
McGoodwin
Lee
L
Hagemann
Tracy
T
D000700:Analgesics / Q000009:adverse effects*; D000928:Antidepressive Agents / Q000009:adverse effects*; D002648:Child; D018680:Cholinergic Antagonists; D003511:Cyclohexanols / Q000009:adverse effects*; D003692:Delayed-Action Preparations / Q000009:adverse effects; D062787:Drug Overdose; D006801:Humans; D008297:Male; D008508:Medication Errors; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000378:metabolism; D016055:Urinary Retention / Q000139:chemically induced; D000069470:Venlafaxine Hydrochloride
D000700:Analgesics; D000928:Antidepressive Agents; D018680:Cholinergic Antagonists; D003511:Cyclohexanols; D003692:Delayed-Action Preparations; D011950:Receptors, Cholinergic; D000069470:Venlafaxine Hydrochloride